DNA topoisomerase II poisons and inhibitors.
Capranico
G
G
Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
Giaccone
G
G
Zunino
F
F
Garattini
S
S
D'Incalci
M
M
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D004250:DNA Topoisomerases, Type II / Q000737:chemistry / Q000502:physiology; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D011034:Podophyllotoxin / Q000031:analogs & derivatives / Q000494:pharmacology; D059005:Topoisomerase II Inhibitors
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D059005:Topoisomerase II Inhibitors; C080080:NK 611; D005047:Etoposide; D004250:DNA Topoisomerases, Type II; D011034:Podophyllotoxin